Table 2

Geometric mean cough frequency (coughs/hour) and the ratio (omeprazole:placebo) of geometric means at the end of treatment, adjusted for baseline cough frequency (complete-case analysis set; n=40)

Omeprazole (n=20)Placebo (n=20)
Baseline
geometric mean (95% CI)
End of treatment
geometric mean (95% CI)
Baseline
geometric mean (95% CI)
End of treatment
geometric mean (95% CI)
Ratio of geometric means at end of treatment, adjusted for baseline
(95% CI)
24 hours8.2 (5.4 to 12.7)4.6 (2.4 to 8.7)9.1 (6.8 to 12.2)8.3 (5.3 to 12.9)0.609 (0.340 to 1.093)
Awake/daytime10.8 (6.8 to 17.0)6.1 (3.2 to 11.8)11.8 (8.9 to 15.8)10.7 (6.7 to 17.2)0.629 (0.354 to 1.119)
Asleep/night-time1.7 (0.9 to 3.3)1.1 (0.6 to 2.0)2.3 (1.1 to 4.7)2.1 (1.2 to 3.7)0.553 (0.267 to 1.146)